SCHEMBL20907615

SCHEMBL20907615

CC(C)OC(=O)c1ccc(-n2cncn2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
CA12 O43570 2/20 0.50
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
CA7 P43166 2/20 0.50
CA9 Q16790 2/20 0.50
CA14 Q9ULX7 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.47
KDM4E B2RXH2 1/20 0.47
PDCD1 Q15116 1/20 0.46
CD274 Q9NZQ7 1/20 0.46
MAPT P10636 2/20 0.46
HSP90AA1 P07900 1/20 0.46
HTT P42858 1/20 0.46
TSHR P16473 1/20 0.46
CYP1A2 P05177 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
CYP3A4 P08684 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL63446 0.83 CYP1A2 (0.62) ALDH1A1CA12CA1CA2CA7
SCHEMBL17321379 0.80 SMN1; SMN2 (0.51) ALDH1A1SMN1; SMN2KDM4EMAPTHSP90AA1
SCHEMBL5734578 0.79 MAPT (0.62) ALDH1A1CA12CA1CA2CA7
SCHEMBL28755979 0.77 SMN1; SMN2 (0.59) ALDH1A1SMN1; SMN2KDM4EMAPTHSP90AA1
SCHEMBL327641 0.76 SMN1; SMN2 (0.58) ALDH1A1SMN1; SMN2KDM4EMAPTHSP90AA1
SCHEMBL23681645 0.76 NPC1 (0.54) ALDH1A1SMN1; SMN2KDM4EMAPTHTT
SCHEMBL701832 0.75 CA12 (0.83) ALDH1A1CA12CA1CA2CA7
SCHEMBL461848 0.74 SMN1; SMN2 (0.56) ALDH1A1SMN1; SMN2KDM4EMAPTHSP90AA1
SCHEMBL2905639 0.74 SMN1; SMN2 (0.56) ALDH1A1SMN1; SMN2KDM4EMAPTHSP90AA1
SCHEMBL23114898 0.74 ALDH1A1 (0.48) ALDH1A1CA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11352329-B2 HIV protease inhibitors GILEAD SCIENCES, INC. (US) 2022-06-07 US disclosed
US-20210078959-A1 HIV PROTEASE INHIBITORS GILEAD SCIENCES, INC. 2021-03-18 US disclosed
WO-2019075291-A1 1-BENZYL-2-IMINO-4-PHENYL-5-OXOIMIDAZOLIDINE DERIVATIVES AS HIV PROTEASE INHIBITORS GILEAD SCIENCES, INC. (US) 2019-04-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210078959-A1 HIV PROTEASE INHIBITORS PRSS1, SERPINB1, FURIN ALDH1A1 1247/4885CA12 2993/4885CA1 2034/4885
US-11352329-B2 HIV protease inhibitors PRSS1, SERPINB1, FURIN ALDH1A1 1247/4885CA12 2993/4885CA1 2034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.